Leticia Ely

507 total citations
9 papers, 372 citations indexed

About

Leticia Ely is a scholar working on Pulmonary and Respiratory Medicine, Epidemiology and Infectious Diseases. According to data from OpenAlex, Leticia Ely has authored 9 papers receiving a total of 372 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Pulmonary and Respiratory Medicine, 4 papers in Epidemiology and 3 papers in Infectious Diseases. Recurrent topics in Leticia Ely's work include Inhalation and Respiratory Drug Delivery (4 papers), Herpesvirus Infections and Treatments (3 papers) and SARS-CoV-2 and COVID-19 Research (2 papers). Leticia Ely is often cited by papers focused on Inhalation and Respiratory Drug Delivery (4 papers), Herpesvirus Infections and Treatments (3 papers) and SARS-CoV-2 and COVID-19 Research (2 papers). Leticia Ely collaborates with scholars based in Canada, United States and Switzerland. Leticia Ely's co-authors include Raimar Löbenberg, Wilson Roa, Warren H. Finlay, Atul Humar, Oriol Manuel, Shahid Husain, Michael G. Ison, Jayant Kalpoe, Maha Assi and Michele I. Morris and has published in prestigious journals such as Clinical Infectious Diseases, European Journal of Pharmaceutics and Biopharmaceutics and The Journal of Heart and Lung Transplantation.

In The Last Decade

Leticia Ely

8 papers receiving 363 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Leticia Ely Canada 6 258 76 65 48 47 9 372
Maria J. Patterson United States 9 122 0.5× 41 0.5× 80 1.2× 5 0.1× 21 0.4× 19 286
Kiyanna Williams United States 8 119 0.5× 30 0.4× 90 1.4× 7 0.1× 62 1.3× 15 272
Vishakha Sabharwal United States 12 157 0.6× 50 0.7× 49 0.8× 40 0.8× 31 0.7× 36 580
R J Coker United Kingdom 10 226 0.9× 56 0.7× 143 2.2× 15 0.3× 42 0.9× 17 457
Víctor Vinuesa Spain 10 172 0.7× 19 0.3× 88 1.4× 3 0.1× 57 1.2× 24 273
Dragana Orlovic South Africa 7 150 0.6× 38 0.5× 209 3.2× 15 0.3× 5 0.1× 9 346
Karin Lindahl Sweden 13 513 2.0× 7 0.1× 156 2.4× 22 0.5× 29 0.6× 30 770
G. Wayne Raborn Canada 8 297 1.2× 7 0.1× 41 0.6× 8 0.2× 20 0.4× 12 342
Tahoora Mousavi Iran 12 129 0.5× 13 0.2× 95 1.5× 3 0.1× 39 0.8× 50 407
Concepción Figueras Spain 7 146 0.6× 11 0.1× 80 1.2× 4 0.1× 20 0.4× 7 416

Countries citing papers authored by Leticia Ely

Since Specialization
Citations

This map shows the geographic impact of Leticia Ely's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Leticia Ely with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Leticia Ely more than expected).

Fields of papers citing papers by Leticia Ely

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Leticia Ely. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Leticia Ely. The network helps show where Leticia Ely may publish in the future.

Co-authorship network of co-authors of Leticia Ely

This figure shows the co-authorship network connecting the top 25 collaborators of Leticia Ely. A scholar is included among the top collaborators of Leticia Ely based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Leticia Ely. Leticia Ely is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

9 of 9 papers shown
1.
Manuel, Oriol, Shahid Husain, Dinesh Kumar, et al.. (2012). Assessment of Cytomegalovirus-Specific Cell-Mediated Immunity for the Prediction of Cytomegalovirus Disease in High-Risk Solid-Organ Transplant Recipients: A Multicenter Cohort Study. Clinical Infectious Diseases. 56(6). 817–824. 211 indexed citations
2.
Manuel, Oriol, Atul Humar, Leticia Ely, et al.. (2011). Low-dose intradermal versus intramuscular trivalent inactivated seasonal influenza vaccine in lung transplant recipients. The Journal of Heart and Lung Transplantation. 30(6). 679–684. 45 indexed citations
3.
Manuel, Oriol, Abhinav Humar, Dale Lien, et al.. (2010). A Randomized Controlled Trial Comparing Intradermal vs. Intramuscular Influenza Vaccine in Lung Transplant Recipients. IRIS. 1 indexed citations
4.
Altamirano‐Diaz, Luis, Lori J. West, Atul Humar, et al.. (2010). Early post‐transplant vaccination with pandemic influenza A/H1N1 vaccine in pediatric heart transplant recipients. Pediatric Transplantation. 15(2). 172–175. 10 indexed citations
5.
Ely, Leticia, Wilson Roa, Warren H. Finlay, & Raimar Löbenberg. (2006). Effervescent dry powder for respiratory drug delivery. European Journal of Pharmaceutics and Biopharmaceutics. 65(3). 346–353. 65 indexed citations
6.
Ely, Leticia, Raimar Löbenberg, Zhaolin Wang, et al.. (2006). Development of Inhalable Nanoparticles. 193–195.
7.
Stuart, Diana, Raimar Löbenberg, Shirzad Azarmi, et al.. (2006). Biophysical Investigation of Nanoparticle Interactions with Lung Surfactant Model Systems. Journal of Biomedical Nanotechnology. 2(3). 245–252. 24 indexed citations
8.
Ely, Leticia, Raimar Löbenberg, Warren H. Finlay, & Wilson Roa. (2006). Optimizing Inhalable Nanoparticles. 125–126. 12 indexed citations
9.
Hinks, D. G., et al.. (2000). Reaction of YBa2Cu 3O6 with Br2: oxidation and formation of nanoscale YBa2Cu3O7. Physica C Superconductivity. 333(1-2). 1–12. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026